News & Events CTI CEO to Present at Cell & Gene Meeting on the Mesa

CTI CEO to Present at Cell & Gene Meeting on the Mesa

October 3, 2017

CTI Clinical Trial & Consulting Services CEO To Present at Cell & Gene Meeting on the Mesa 

FOR IMMEDIATE RELEASE [Covington, KY ~ October 3, 2017]

CTI Clinical Trial and Consulting Services (CTI), a global, privately held, full-service contract research organization, will present at the 2017 Cell & Gene Meeting on the Mesa, taking place in La Jolla, CA October 4-6, 2017. CTI’s Chief Executive Officer, Timothy J. Schroeder, will participate as part of the "Development of Cellular Therapies Workshop". He will join leaders from QuintilesIMS, Fate Therapeutics, Capricor Therapeutics, and BlueRock Therapeutics for the panel discussion in Session 1: Development of Cellular Therapies, taking place Wednesday October 4th at 7:15a local time.

“We’re honored to be sponsoring and presenting at the 2017 Cell & Gene Meeting on the Mesa, where so many thought leaders in the industry come together,” according to Schroeder. “We believe that CTI's extensive experience in cell and gene therapy, as well as our partnership with the Alliance demonstrate our belief that diagnosis and treatment paradigms will change dramatically in the near future based on these advances."

CTI is also a supporting member of the Alliance for Regenerative Medicine, and is a proud sponsor of the 2017 Cell & Gene Meeting on the Mesa.

Timothy Schroeder, CEO and Founder of CTI, has over 35 years of clinical, academic, and industry experience in global drug and device development programs. CTI, founded in 1999, is a multi-national research firm with associates in North America, Europe, Latin America and Asia-Pacific. The firm has supported more than 100 drug and device approvals, and currently works on behalf of approximately 120 global pharmaceutical and biotechnology companies. Prior to founding CTI, Tim held numerous faculty positions with the University of Cincinnati College of Medicine. He was also the founding Executive Vice President of Clinical Development at SangStat Medical Corporation, which went public in 1995. Tim is currently a board member for over a dozen corporate and non-profit organizations, including Xavier University, which he attended. Tim was named as an EY Entrepreneur of the Year in 2015 and was recognized as Top Leader by the Enquirer Media in 2016.

About The Cell & Gene Meeting on the Mesa

The Cell & Gene Meeting on the Mesa is a three-day conference bringing together senior executives and top decision-makers in the industry with the scientific community to advance cutting-edge research into cures. The meeting features a nationally recognized Scientific Symposium, attended by leading researchers and clinical experts from around the globe, in conjunction with the industry's premier annual Partnering Forum, the first event of its kind dedicated solely to facilitating connections in this sector. Combined, these meetings attract over 850 attendees, fostering key partnerships through more than 1100 one-on-one meetings while highlighting the significant clinical and commercial progress in the field.

About CTI Clinical Trial and Consulting Services

CTI Clinical Trial and Consulting Services is a global, privately held, full-service contract research organization (CRO), delivering a complete spectrum of clinical trial and consulting services throughout the lifecycle of development, from concept to commercialization. CTI’s focused therapeutic approach provides pharmaceutical, biotechnology, and medical device firms with clinical and disease area expertise in rare diseases, regenerative medicine/gene therapy, immunology, transplantation, nephrology, hematology/oncology, neurology, infectious diseases, hepatology, cardiopulmonary, and pediatric populations. CTI also offers a fully integrated multi-specialty clinical research site that conducts phase I-IV trials. CTI has a passion for helping life-changing therapies succeed in chronically and critically ill patient populations. With clinical trial experience across 6 continents, CTI partners with research sites, patients, and sponsors to fulfill unmet medical needs. CTI is headquartered in the Greater Cincinnati, OH area, with operations across North America, Europe, Latin America, and Asia-Pacific. For more information visit www.ctifacts.com

 

Media Contact

Allison Schroeder - CTI | 513.598.9290 | aschroeder@ctifacts.com

Join Our Mailing List